Is FDG -PET-CT A Valuable Tool in Prediction of Persistent Disease in Head and Neck Cancer |
Uzel, Esengul Kocak
(Radiation Oncology, Sisli Etfal Teaching and Research Hospital)
Ekmekcioglu, Ozgul (Nuclear Medicine, Cerrahpasa Medical Faculty) Elicin, Olgun (Radiation Oncology, Cerrahpasa Medical Faculty) Halac, Metin (Nuclear Medicine, Cerrahpasa Medical Faculty) Uzel, Omer Erol (Radiation Oncology, Cerrahpasa Medical Faculty) |
1 | Andrade RS, Heron DE, Degirmenci B, et al (2006). Post-treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys, 65, 1315-22. DOI ScienceOn |
2 | Bastiaannet E, Groen H, Jager PL, et al (2004). The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas: A systematic review and meta-analysis. Cancer Treat Rev, 30, 83-101. DOI ScienceOn |
3 | De Santis M, Becherer A, Bokemeyer C, et al (2004). 2-[18]Fluoro- deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol, 22, 1034-9. DOI ScienceOn |
4 | Ding M, Newman F, Raben D (2005). New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngol Clin North Am, 38, 371-95. DOI ScienceOn |
5 | Eisbruch A, Marsh LH, Dawson LA, et al (2004). Recurrences near base of skull after IMRT for head-and-neck cancer: Implica- tions for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys, 59, 28-42. DOI ScienceOn |
6 | El-Sayed S, Nelson N (1996). Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and random- ized trials. J Clin Oncol, 14, 838-47. |
7 | Hain SF, O'Doherty MJ, Timothy AR, et al (2000). Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med, 27, 590-4 DOI |
8 | HigginsKA, Hoang JK, Roach MC, et al (2012). Analysis of Pretreatment FDG-PET SUV parameters in Head-and-Neck Cancer: Tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys, 82, 548-53 DOI ScienceOn |
9 | Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observations. J Am Statist Assoc, 53, 457-81 DOI ScienceOn |
10 | Lee N, Xia P, Fischbein NJ, (2003). Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys, 57, 49-60. DOI ScienceOn |
11 | Lefebvre JL, Chevalier D, Luboinski B, et al (1996). Larynx preservation in pyriform sinus cancer: Preliminary results of a Eu- ropean Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst, 88, 890-9. DOI ScienceOn |
12 | Mantel N (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep, 5, 163-70 |
13 | Moeller BJ, Rana V, Cannon BA, et al (2009). Prospective risk-adjuste [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol, 20, 2509-15. |
14 | Murphy JD, La TH, Chu K, et al (2011). Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys, 80, 514-21. DOI ScienceOn |
15 | Pfister DG, Shaha AR, Harrison LB (1997). The role of chemotherapy in the curative treatment of head and neck cancer. Surg Oncol Clin N Am, 6, 749-68 |
16 | Paccagnella A, Orlando A, Marchiori C, et al (1994). Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst, 86, 265-72. DOI ScienceOn |
17 | Paola Castaldi,Vittoria Rufini,Francesco Bussu, et al (2012). Can early and late 18F-FDG PET.CT be used as prognostic factors.for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Radiother Oncol, 3, 63-8. |
18 | Passero VA, Branstetter BF, Shuai Y, et al (2010). Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol, 21, 2278-83 DOI ScienceOn |
19 | Pignon JP, le Maitre A, Maillard E, Bourhis J, (2009). Meta-analysis of chemo- therapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients. Radiother Oncol, 92, 4-14. DOI ScienceOn |
20 | Prestwich RJ, Subesinghe M, Gilbert A, et al (2012). Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma. Clin Radiol, 67, 966-75. DOI ScienceOn |
21 | Rose PG, Adler LP, Rodriguez M, et al (1999). Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol, 17, 41-5. |
22 | Scarfone C, Lavely WC, Cmelak AJ, et al (2004). Prospective feasibil- ity trial of radiotherapy target definition for head and neck can- cer using 3-dimensional PET and CT imaging. J Nucl Med, 45, 543-52. |
23 | Wong RJ, Lin DT, Schoder H et al (2002). Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma. J Clin Oncol, 20, 4199-208. DOI ScienceOn |
24 | Schwartz DL, Ford E, Rajendran J, et al (2005). FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 61, 129-36. DOI ScienceOn |
25 | Trautmann TG, Zuger JH, (2005). Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal Canal: Mol Imaging Biol, 7, 309-13. DOI |
26 | Troost EG, Schinagl DA, Bussink J, Oyen WJ, Kaanders JH (2010). Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol, 96, 328-34. DOI ScienceOn |
27 | Yanagawa M, Tatsumi M, Miyata H, et al (2012). Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer: PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria in Solid Tumors. J Nucl Med, 53, 872-80. DOI ScienceOn |
28 | Yao M, Smith RB, Graham MM, et al (2005). The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys, 63, 991-9 DOI ScienceOn |
![]() |